TipRanks
Immunome (IMNM)
NASDAQ:IMNM
US Market
IMNM
Immunome
RESEARCH TOOLSreports
Want to see IMNM full AI Analyst Report?

Immunome (IMNM) Stock News & Sentiment

466 Followers
Immunome Restructures BMS Deal, Gains Key Patent Rights
Premium
Company Announcements
Immunome Restructures BMS Deal, Gains Key Patent Rights
8d ago
8K
IMNM
Immunome: Advancing Pipeline and Strong Cash Runway Underpin Reiterated Buy Rating and Unchanged $40 Price Target
Premium
Ratings
Immunome: Advancing Pipeline and Strong Cash Runway Underpin Reiterated Buy Rating and Unchanged $40 Price Target
2M ago
IMNM
FDA NDA Acceptance and Strong RINGSIDE Data Support Immunome Buy Rating and Unchanged $40 Price Target
Premium
Ratings
FDA NDA Acceptance and Strong RINGSIDE Data Support Immunome Buy Rating and Unchanged $40 Price Target
3M ago
IMNM
Analyst Brian Cheng Initiates Buy on Immunome, Citing Differentiated Pipeline and Compelling Risk‑Reward Profile
Premium
Ratings
Analyst Brian Cheng Initiates Buy on Immunome, Citing Differentiated Pipeline and Compelling Risk‑Reward Profile
4M ago
IMNM
Immunome’s New Radiopharma Trial Puts IMNM on Early Oncology Watchlists
Premium
Company Announcements
Immunome’s New Radiopharma Trial Puts IMNM on Early Oncology Watchlists
4M ago
IMNM
Immunome shareholders reaffirm board, auditor and pay policies
Premium
Company Announcements
Immunome shareholders reaffirm board, auditor and pay policies
4M ago
8K
IMNM
Charles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile
Premium
Ratings
Charles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile
4M ago
IMNM
More IMNM News >

IMNM News on the Web

Enavate Sciences GP, LLC Reduces Zenas BioPharma Inc (ZBIO) Stake
GuruFocus News
Neutral
SILVERARC CAPITAL MANAGEMENT, LLC Trims Elutia Inc (ELUT) Stake -- Shares Look 11% Overvalued ...
GuruFocus News
Neutral
SilverArc Capital Management Exits KalVista Pharmaceuticals (KALV) Position Entirely
GuruFocus News
Neutral
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stake -- Shares Trade 55% Below GF Value
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Immunome (IMNM)
TipRanks News
Bullish
What This Immunome Sale Means a Day Before a Big FDA Milestone
The Motley Fool
Bullish
Analysts Offer Insights on Healthcare Companies: CervoMed (CRVO), Immunome (IMNM) and Tarsus Pharmaceuticals (TARS)
TipRanks News
Bullish
Immunome Soars As Pipeline Progress Ignites Investor Hopes
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
IMNM
Sector Average
Media Buzz
This Week1 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMNM’s Media Buzz Sentiment?
1 articles about IMNM were published this week. In an average week, 3 articles are published.
    What is IMNM’s weekly average amount of articles?
    In an average week, 3 articles about IMNM are published.
      What is IMNM’s News Sentiment?
      50% of articles about IMNM were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        IQVIQVIA Holdings
        GILDGilead Sciences
        ABBVAbbVie
        VRTXVertex Pharmaceuticals
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week